Nicotinell Mint (Nicotine Bitartrate Dihydrate)

The nicotine in Nicotinell Mint is released as nicotine bitartrate dihydrate and absorbed through the mouth lining. It binds to nicotinic acetylcholine receptors in the brain, providing a mild stimulant effect that mimics the nicotine received from cigarettes. This partial activation eases withdrawal and diminishes the urge to smoke while the user works toward complete cessation.

The appropriate dose of Nicotinell Mint is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and previous quit‑attempt experience. The prescriber selects the number of lozenges per day and the duration of therapy, ensuring the regimen aligns with clinical guidelines for nicotine replacement therapy.

Safety data for nicotine replacement products during pregnancy and lactation are limited, and the pregnancy category for Nicotinell Mint is listed as unknown. Healthcare providers generally recommend avoiding nicotine exposure in these periods unless the benefits outweigh the risks. Patients who are pregnant or breastfeeding should discuss alternative cessation strategies with their clinician.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any necessary import documentation.

Both Nicotinell Mint lozenges and nicotine gum belong to the same nicotine replacement therapy class and aim to reduce cravings. The lozenge provides a discreet, mint‑flavored option that dissolves slowly in the mouth, whereas gum requires chewing to release nicotine. Choice often depends on patient preference, tolerability, and specific dosing schedules recommended by a healthcare professional.

Store Nicotinell Mint at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability. Ensure the container is tightly closed after each use and out of reach of children.

The lozenge is placed in the mouth and allowed to dissolve slowly, without chewing or swallowing whole. Users should avoid eating or drinking for at least 15 minutes before and after use to ensure optimal absorption through the oral mucosa. The recommended frequency and total daily dose are set by the prescriber.

Although uncommon, serious adverse reactions can include allergic responses such as rash, itching, swelling, or difficulty breathing, as well as cardiovascular events like chest pain, palpitations, or hypertension. Patients experiencing any of these symptoms should discontinue use immediately and seek medical attention.

Nicotinell Mint is not recommended for individuals under the legal smoking age, for children, or for patients with known hypersensitivity to nicotine or any component of the lozenge. Caution is also advised for people with uncontrolled cardiovascular disease, severe hypertension, or recent myocardial infarction, and they should consult a healthcare professional before use.